Monogram Orthopaedics, developer of 3D-printed orthopedic implants enabled by robotics with pre-operative imaging, raised USD $17.2 million through the sale of shares. The company commenced trading on NASDAQ with the symbol MGRM.
The company’s proprietary approach to total knee replacement is designed to address problems such as mechanical loosening, bone loss, dislocation, ease of revision and fracture. Using the Monogram software platform and product solution architecture, surgeons will be able to design optimized implants that improve stability and physiological loading.
Monogram Orthopaedics, developer of 3D-printed orthopedic implants enabled by robotics with pre-operative imaging, raised USD $17.2 million through the sale of shares. The company commenced trading on NASDAQ with the symbol MGRM.
Monogram Orthopaedics, developer of 3D-printed orthopedic implants enabled by robotics with pre-operative imaging, raised USD $17.2 million through the sale of shares. The company commenced trading on NASDAQ with the symbol MGRM.
The company’s proprietary approach to total knee replacement is designed to address problems such as mechanical loosening, bone loss, dislocation, ease of revision and fracture. Using the Monogram software platform and product solution architecture, surgeons will be able to design optimized implants that improve stability and physiological loading.
Copy to clipboard 
